Track the Cyxone AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. The latest transaction was reported on 4 March 2021 (Purchase). Among the most active insiders: Bert Roland Kari Junno. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Cyxone AB is a Swedish company focused on developing treatments for autoimmune diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.